SOURCE: Kantar Health

Kantar Health

October 14, 2010 12:47 ET

Kantar Health Thought Leaders to Present at 4th Annual National Forum on Issues and Challenges Facing Oncology Stakeholders

NEW YORK, NY--(Marketwire - October 14, 2010) -  Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that two of its oncology thought leaders will be featured speakers at Confera's 4th Annual National Forum on Issues and Challenges Facing Oncology Stakeholders October 20-21, 2010, at the Hilton Back Bay in Boston.

Rhoda Dunn, Account Director, will present "Federal Activism in the U.S. Cancer Drug Market" at 4:15 pm on Wednesday, October 20. Ms. Dunn's presentation will leverage two examples of recent federal activism in the cancer drug marketplace and what they may signal for drug developers in the coming months and years.

Ian Hicks, Senior Vice President, Oncology, will present "Evolving Trends in the Oncology Marketplace" at 9:05 am on Thursday, October 21. Mr. Hicks' presentation will address:

  • Barriers affecting access to cancer therapies
  • Challenges impacting the drug development process
  • Value-based pricing and drug coverage: Where do we go from here?

Before joining Kantar Health, Ms. Dunn was responsible for leading the team to establish a price for Provenge (sipuleucel-T), product branding, messaging, marketing support for the payer team, development of launch marketing materials, and convention and medical marketing. She has more than 16 years of consulting experience focusing on business development, brand strategy, communications, and measures of ROI.

Mr. Hicks has significant oncology expertise, with over 35 years of experience in both the pharmaceutical and biotechnology industries. Mr. Hicks has extensive oncology and related therapeutic product commercialization experience. This experience, along with extensive market strategy planning in the U.S., Europe, and Japan, provides the basis for insight and discussion.

For more information on the 4th Annual National Forum on Economics Issues and Challenges Facing Oncology Stakeholders, visit the conference website.

Thought leaders from Kantar Health speak at many conferences in the U.S., Europe and Asia throughout the year. For more information, please visit our event calendar.

About Kantar Health (
Kantar Health is a leading healthcare-focused global consultancy, specializing in portfolio optimization, market access, safety and outcomes, and brand and customer insights. Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, it is the next-generation decision support partner to the pharmaceutical and biotech industries, delivering evidence-based guidance to support clients' global and local success.

With 40+ offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa, Kantar Health provides the broadest global footprint, coupled with the strongest local knowledge to help drive clients' maximum performance in every geography. Market-leading solutions ensure optimal decisions and actions across the brand life cycle, from assessing opportunities and sizing markets... to developing products and building access positioning brands and creating messaging... to managing stakeholder relationships and monitoring treatment outcomes.

Contact Information

  • Contact Information
    For more information on Kantar Health, please contact:
    Paula Paradise
    Vice President of Global Marketing
    Email Contact